Published in Business Times 21 June 2023: “Wanted: experts to sit on startups’ scientific advisory boards”
###
About Axcynsis Therapeutics Pte. Ltd.
Axcynsis Therapeutics Pte. Ltd. is a platform-based biotechnology company focusing on the development of Antibody Drug Conjugates (ADCs) to revolutionise cancer treatments. The Singapore biotech start-up leverages on proprietary technologies in its development of a robust pipeline of ADC candidates to address unmet medical needs for cancer treatment.
For all media queries, please contact:
contactus@axcynsis.com
